{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:52:55Z","timestamp":1773273175763,"version":"3.50.1"},"reference-count":15,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1507\/endocrj.k10e-130","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T05:20:19Z","timestamp":1282540819000},"page":"873-880","source":"Crossref","is-referenced-by-count":30,"title":["Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma"],"prefix":"10.1507","volume":"57","author":[{"given":"Shuichi","family":"Sato","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Muraishi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Tokubuchi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tajiri","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetaka","family":"Suekane","sequence":"additional","affiliation":[{"name":"Department of Urology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Urology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Urology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hiromatsu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Torino F, Corsello SM, Longo R, Barnabei A, Gasparini G. (2009) Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. <i>Nat Rev Clin Oncol <\/i>6: 219-228.","DOI":"10.1038\/nrclinonc.2009.4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ivy SP, Wick JY, Kaufman BM. (2009) An overview of small-molecule inhibitors of VEGFR signaling. <i>Nat Rev Clin Oncol <\/i>6: 569-579.","DOI":"10.1038\/nrclinonc.2009.130"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. (2007) Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. <i>J Natl Cancer Inst <\/i>99: 81-83.","DOI":"10.1093\/jnci\/djk008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wong E, Rosen LS, Mulay M, Vanvugt A, Dinolfo M, Tomoda C, Sugawara M, Hershman JM. (2007) Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. <i>Thyroid <\/i>17: 351-355.","DOI":"10.1089\/thy.2006.0308"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK. (2006) Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. <i>Ann Intern Med <\/i>145: 660-664.","DOI":"10.7326\/0003-4819-145-9-200611070-00008"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0586"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604497"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vetter ML, Kaul S, Iqbal N. (2008) Tyrosine kinase inhibitors and the thyroid as both an unintended and an intended target. <i>Endocr Pract <\/i>14: 618-624.","DOI":"10.4158\/EP.14.5.618"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0349"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03253.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0104"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI. (2008) Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. <i>Ann Oncol <\/i>19: 265-268.","DOI":"10.1093\/annonc\/mdm483"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM. (2006) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. <i>Am J Physiol Heart Circ Physiol <\/i>290: H547-559.","DOI":"10.1152\/ajpheart.00616.2005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Makita N, Miyakawa M, Fujita T, Iiri T.(2010) Sunitinib induces hypothyroidism with a markedly reduced vascularity. <i>Thyroid <\/i>20: 323-326.","DOI":"10.1089\/thy.2009.0414"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0125"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/10\/57_K10E-130\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:53:45Z","timestamp":1618296825000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/10\/57_K10E-130\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-130","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}